HUP9903935A2 - D-vitamin analógokat tartalmazó gyógyszerkészítmények - Google Patents

D-vitamin analógokat tartalmazó gyógyszerkészítmények

Info

Publication number
HUP9903935A2
HUP9903935A2 HU9903935A HUP9903935A HUP9903935A2 HU P9903935 A2 HUP9903935 A2 HU P9903935A2 HU 9903935 A HU9903935 A HU 9903935A HU P9903935 A HUP9903935 A HU P9903935A HU P9903935 A2 HUP9903935 A2 HU P9903935A2
Authority
HU
Hungary
Prior art keywords
analogues
vitamin
pharmaceutical compositions
medicinal preparations
clathrates
Prior art date
Application number
HU9903935A
Other languages
English (en)
Inventor
Karin Hoffmann
Jutta Riedl
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of HUP9903935A2 publication Critical patent/HUP9903935A2/hu
Publication of HUP9903935A3 publication Critical patent/HUP9903935A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Abstract

A találmány tárgyát ciklődextrin-klatrátőkat és D-vitamin-analógőkatmint kalcitriőlt tartalmazó tőpikűsan alkalmazható,gyógyszerkészítmények képezik. A találmány szerintigyógyszerkészítmények psőriasis kezelésére szőlgálnak. ŕ
HU9903935A 1995-12-21 1996-12-20 Pharmaceutical compositions with vitamin d analogues HUP9903935A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19549243A DE19549243A1 (de) 1995-12-21 1995-12-21 Pharmazeutische Präparate enthaltend Clathrate von Cyclodextrinen und nichtnatürliche Vitamin D-Analoga
PCT/EP1996/005856 WO1997023242A1 (de) 1995-12-21 1996-12-20 Pharmazeutische präparate mit vitamin d-analoga

Publications (2)

Publication Number Publication Date
HUP9903935A2 true HUP9903935A2 (hu) 2000-03-28
HUP9903935A3 HUP9903935A3 (en) 2000-05-29

Family

ID=7781710

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903935A HUP9903935A3 (en) 1995-12-21 1996-12-20 Pharmaceutical compositions with vitamin d analogues

Country Status (12)

Country Link
EP (1) EP0869819A1 (hu)
JP (1) JP2000502733A (hu)
KR (1) KR19990076637A (hu)
CN (1) CN1207687A (hu)
AU (1) AU1306997A (hu)
CA (1) CA2241205A1 (hu)
DE (1) DE19549243A1 (hu)
HU (1) HUP9903935A3 (hu)
IL (1) IL125020A0 (hu)
IS (1) IS4774A (hu)
NO (1) NO982874L (hu)
WO (1) WO1997023242A1 (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
DE102005017775A1 (de) * 2005-04-13 2006-10-19 Schering Ag Komplexe aus Vitamin D-Verbindungen oder deren Analoga mit einem 5Z,7E,10(19)-Trien-System und methlierten Derivaten des ß-Cyclodextrins
ES2904546T3 (es) 2006-02-03 2022-04-05 Opko Renal Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
WO2008008608A2 (en) 2006-06-21 2008-01-17 Proventiv Therapeutics, Llc Method of treating and preventing secondary hyperparathyroidism
KR100822133B1 (ko) * 2006-11-06 2008-04-15 한미약품 주식회사 비타민 ｄ 또는 이의 유도체의 고체분산체 및비스포스포네이트를 포함하는, 골다공증 예방 또는 치료용복합제제
JP5444212B2 (ja) 2007-04-25 2014-03-19 シトクロマ インコーポレイテッド ビタミンｄ不足および欠乏症の治療方法
US20100144684A1 (en) 2007-04-25 2010-06-10 Proventiv Therapeutics, Inc. Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease
WO2008134518A2 (en) 2007-04-25 2008-11-06 Cytochroma Inc. Methods and compounds for vitamin d therapy
PL2148661T3 (pl) 2007-04-25 2013-07-31 Cytochroma Inc Doustne kompozycje o kontrolowanym uwalnianiu zawierające związek będący witaminą D i woskowy nośnik
KR101852042B1 (ko) 2008-04-02 2018-04-25 사이토크로마 인코포레이티드 비타민 ｄ 결핍 및 관련 장애에 유용한 방법, 조성물, 용도 및 키트
ES2783980T3 (es) 2010-03-29 2020-09-21 Opko Ireland Global Holdings Ltd Métodos y composiciones para la reducción de niveles de paratiroides
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
SG11201700858RA (en) 2014-08-07 2017-03-30 Opko Ireland Global Holdings Ltd Adjunctive therapy with 25-hydroxyvitamin d
TWI747893B (zh) 2016-03-28 2021-12-01 愛爾蘭商歐科愛爾蘭全球控股股份有限公司 維生素ｄ治療之方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177586B (en) * 1978-12-19 1981-11-28 Chinoin Gyogyszer Es Vegyeszet New process for preparing stable inclusion complexes of vitamine d with cyclodextrin
JPS5910562A (ja) * 1982-07-07 1984-01-20 Teijin Ltd プレ−１α−ヒドロキシコレカルシフエロ−ル類の製造法
JPS5936656A (ja) * 1982-08-23 1984-02-28 Teijin Ltd 新規包接化合物及びそれを活性成分とする薬剤
JPS60120812A (ja) * 1983-12-02 1985-06-28 Teijin Ltd 糖尿病性骨減少症治療剤
ATE104554T1 (de) * 1990-01-10 1994-05-15 Hoffmann La Roche Topische praeparate.
IL107185A (en) * 1992-10-06 1998-02-22 Schering Ag History of 52-carboxylic acid, processes for their preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
IL125020A0 (en) 1999-01-26
NO982874D0 (no) 1998-06-19
KR19990076637A (ko) 1999-10-15
CN1207687A (zh) 1999-02-10
DE19549243A1 (de) 1997-06-26
NO982874L (no) 1998-08-20
JP2000502733A (ja) 2000-03-07
HUP9903935A3 (en) 2000-05-29
AU1306997A (en) 1997-07-17
WO1997023242A1 (de) 1997-07-03
IS4774A (is) 1998-06-15
EP0869819A1 (de) 1998-10-14
CA2241205A1 (en) 1997-07-03

Similar Documents

Publication Publication Date Title
HUP9903935A2 (hu) D-vitamin analógokat tartalmazó gyógyszerkészítmények
MXPA03003511A (es) Composicion topica que contiene al menos una vitamina d o un analogo de vitamina de y al menos un corticosteroide.
NL300017I1 (nl) Gesubstitueerde androsta-1,4-dieen-3,17-dionen, alsmede farmaceutische preparaten die dergelijke verbindingen bevatten.
LU90366I2 (fr) Nasonex
GR1000456B (el) Μεθοδος παρασκευης φαρμακευτικων συνθεσεων που περιλαμβανουν κυκλοσπορινες.
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
GB2380675A (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
SV1995000042A (es) Heteroaril-oxazolidinonas de 5 eslabones ref. le a 30523-sv
DK0994710T3 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzhydrylpiperazin og en cyclodextrin
IL75637A (en) Thymopentin analogs and pharmaceutical compositions containing them
ATE202931T1 (de) Taxanderivate enthaltende arzneizubereitungen
SE9602442D0 (sv) Administration of pharmaceuticals
NO980317L (no) Anvendelse av Calendula-glykosider for behandling av psoriasis
ES2195040T3 (es) Conjugado que incluye un principio activo, un polipeptido y varios polieteres y su uso como medicamento.
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
ATE227122T1 (de) Stabilisierte tablettenformulierung
TR200002293T2 (tr) Farmasötik bileşimler.
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
DK0612763T3 (da) Cykliske angiopeptinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
UA32583C2 (uk) Похідні арилтіоалкілтіопіридину
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
AR003452A1 (es) Dimaleato de n,n-dietil-8,8-dipropil-2-azaspiro [4.5]decano-2-propanamina y una composicion farmaceutica que lo comprende.
IL119412A (en) Gonadotropins and pharmaceutical compositions containing them